seri
novel
amino
acid
peptid
mycophenol
acid
mpa
deriv
obtain
potenti
antibacteri
agent
coupl
mpa
respect
amin
optim
condens
reagent
edcidmap
amino
acid
analog
receiv
methyl
ester
also
free
carboxyl
group
biolog
activ
product
test
five
refer
bacteri
strain
klebsiella
pneumonia
atcc
esbl
escherichia
coli
atcc
pseudomona
aeruginosa
atcc
staphylococcu
aureu
mrsa
atcc
staphylococcu
aureu
mssa
atcc
peptid
deriv
prove
versatil
one
mic
valu
rel
strain
lower
mpa
alon
note
activ
amino
acid
deriv
depend
configur
chiral
center
amino
acid
unit
methyl
ester
indic
better
antimicrobi
activ
analog
free
carboxyl
group
mycophenol
acid
mpa
possess
interest
scope
biolog
properti
includ
antimicrobi
antifung
antivir
immunosuppress
antitumor
featur
mpa
fig
discov
italian
physician
bartolomeo
gosio
collect
fungu
damag
maiz
call
penicillium
glaucum
found
fungu
exhibit
antimicrobi
activ
anthrax
bacterium
although
mpa
occur
first
antibiot
isol
pure
crystallin
form
studi
continu
long
time
biochem
caus
immunodefici
investig
children
inosin
monophosph
dehydrogenas
impdh
establish
enzym
respons
undesir
immun
respons
autoimmun
diseas
studi
toward
suitabl
inhibitor
start
follow
success
clinic
trial
compound
trade
name
cell
cept
fig
approv
use
kidney
transplant
us
food
drug
administr
mpa
competit
revers
inhibitor
monophosph
dehydrogenas
impdh
predominantli
isoform
ii
present
tumor
cell
activ
lymphocyt
mpa
activ
substanc
immunosuppress
drug
prevent
acut
chronic
reject
allogen
organ
transplant
far
clinic
appli
two
deriv
mpa
mycophenol
mofetil
mmf
known
cellcept
produc
roch
mycophenol
sodium
mp
fig
trade
name
myfort
manufactur
novarti
mpa
possess
signific
antimicrobi
properti
eg
anthrax
bacterium
botryti
cinerea
antifung
like
rhizoctonia
solani
antivir
instanc
dengu
viru
avian
reovirus
arv
coronavirus
merscov
rotaviru
mycophenol
acid
exhibit
also
wide
spectrum
anticanc
properti
recent
studi
show
combin
rapamycin
mpa
significantli
improv
clinic
symptom
erythema
edema
rash
rash
atop
dermat
also
reduc
epiderm
exfoli
edema
cellulit
hand
multidrug
resist
also
signific
problem
treatment
bacteri
infect
structur
modif
mpa
could
provid
promis
antimicrobi
agent
take
account
larg
number
posit
aspect
mpa
attempt
modifi
structur
toward
microbiolog
activ
optim
synthesi
sever
new
amino
acid
peptid
mpa
deriv
conjug
variou
condens
reagent
new
synthes
compound
test
five
refer
strain
klebsiella
pneumonia
atcc
esbl
escherichia
coli
atcc
pseudomona
aeruginosa
atcc
staphylococcu
aureu
mrsa
atcc
staphylococcu
aureu
mssa
atcc
accord
research
molecular
model
polar
group
end
side
chain
mpa
interact
ser
impdh
one
crucial
factor
mainten
activ
literatur
report
amid
mpa
analog
bear
glycin
alanin
valin
glutam
acid
leucin
phenylalanin
moieti
potenti
anticanc
immunosupress
agent
order
obtain
amid
bond
mpa
molecul
amino
acid
larg
amount
condens
agent
check
exampl
eedq
pyridin
n
n
dicyclohexylcarbodiimid
dcc
nmm
n
n
n
n
hexafluorophosph
hbtu
nmethylomorpholin
nmm
method
mix
anhydrid
isobutyl
chloroform
unfortun
none
method
occur
effect
sinc
low
convers
substrat
difficulti
purif
target
amid
edci
carbodiimid
success
use
condens
reagent
presenc
dmap
without
racem
suppress
synthesi
optic
activ
amino
acid
deriv
amino
group
chiral
amino
acid
acyl
method
prove
suitabl
synthesi
compound
amino
acid
mpa
deriv
obtain
mean
condens
reagent
dimethylaminopropyl
carbodiimid
edci
presenc
dimethylamino
pyridin
dmap
act
base
anhydr
n
ndimethylformamid
dmf
scheme
case
deriv
mpa
isoleucin
malon
moieti
best
result
receiv
use
n
procedur
triethylamin
act
base
propanephosphon
acid
anhydrid
condens
reagent
scheme
method
use
presenc
tea
provid
amid
high
yield
low
epimer
particularli
wellsuit
coupl
racem
prone
acid
amin
includ
rel
nonnucleophil
anilin
easi
reaction
setup
product
isol
final
synthesi
compound
optim
use
method
result
synthesi
mpa
analog
given
tabl
order
investig
influenc
methyl
ester
activ
chosen
microorgan
methyl
ester
hydrolyz
lithium
hydroxid
monohydr
produc
deriv
free
carboxyl
group
scheme
yield
obtain
analog
present
tabl
next
step
obtain
pentapeptid
deriv
contain
structur
tuftsin
retrotuftsin
protect
tuftsin
retrotuftsin
deriv
pentapeptid
synthes
mix
anhydrid
method
isobutyl
chloroform
nmethylmorpholin
nmm
anhydr
dmf
tuftsin
known
natur
immunomodul
wide
rang
biolog
properti
occur
human
blood
mammal
abl
stimul
certain
white
blood
cell
monocyt
macrophag
neutrophil
tetrapeptid
provid
also
antitumor
antimicrobi
anticoagul
analges
properti
despit
advantag
properti
tuftsin
peptid
stabl
halflif
blood
min
hydrolyz
leucin
aminopeptidas
carboxypeptidas
b
proteinas
subtilisin
tripeptid
hlysproargoh
hthrlysprooh
result
compound
inhibit
activ
tuftsin
tuftsin
analog
biolog
activ
compound
mpa
could
improv
metabol
properti
anoth
way
stabil
tuftin
molecul
attach
anoth
amino
acid
group
lysin
thu
form
pentapeptid
could
also
implement
design
conjug
cours
optim
consecut
stage
toward
final
peptid
appli
condens
reagent
edci
eedq
case
tuftsin
analog
effect
one
occur
procedur
presenc
tea
scheme
wherea
compound
bear
retrotuftsin
optim
edci
presenc
dmap
scheme
mycophenol
acid
peptid
coupl
anhydr
dmf
c
produc
mpa
deriv
reason
yield
result
experi
shown
tabl
fmoc
protect
group
remov
diethylamin
solut
toward
target
compound
fmoc
remov
yield
within
rang
present
studi
evalu
effect
obtain
compound
five
refer
strain
klebsiella
pneumonia
atcc
esbl
escherichia
coli
atcc
pseudomona
aeruginosa
atcc
staphylococcu
aureu
mrsa
atcc
staphylococcu
aureu
mssa
atcc
select
compound
differ
structur
skeleton
abl
see
compon
particular
import
antibacteri
activ
micro
dilut
method
broth
gave
possibl
determin
minimum
concentr
microbi
growth
inhibitor
mic
within
narrow
precis
concentr
rang
carri
micropl
studi
analysi
result
may
consist
visual
assess
degre
turbid
given
well
spectrophotomet
test
waterinsolubl
product
compound
arginin
incomplet
dispers
may
interfer
read
absorb
advis
use
color
growth
indic
microorgan
activ
sparingli
solubl
compound
may
erron
present
work
redox
indic
resazurin
use
measur
presenc
live
microorgan
present
test
compound
resazurin
subject
reduct
activ
activ
metabol
microorgan
chang
color
blue
resazurin
pink
resorufin
intens
color
correl
size
popul
found
work
use
resazurin
indic
metabol
activ
bacteria
increas
sensit
detect
standard
antibiot
mpa
e
coli
possibl
determin
bold
type
tabl
remain
compound
test
bacteria
determin
inhibitori
concentr
test
compound
select
microorgan
mgml
shown
tabl
scope
examin
deriv
mpa
chosen
individu
methodolog
basi
elabor
implement
interpret
minim
inhibitori
concentr
eucast
supplement
recommend
scientif
societi
data
public
experi
investig
compound
exert
varieti
effect
depend
speci
bacteria
demonstr
test
bacteri
speci
except
acinetobact
baumannii
mic
mpa
p
aeruginosa
activ
observ
inhibit
compound
mic
mgml
compar
mpa
mgml
case
compound
inhibit
k
pneumonia
compar
control
effect
ampicillin
mgml
compound
mpa
compound
lower
mpa
remain
bacteria
clear
activ
concentr
limit
compound
exhibit
greatest
activ
aureu
mssa
strain
sensit
mrsa
case
analog
aureu
mssa
scheme
synthesi
amino
acid
deriv
mpa
use
edcidmap
method
scheme
synthesi
amino
acid
deriv
mpa
use
method
tabl
yield
obtain
compound
compound
equal
mgml
concentr
limit
higher
bacteriostat
effect
test
compound
pseudomona
aeruginosa
remain
compound
caus
poor
growth
inhibit
control
inhibitori
effect
growth
bacteria
bactericid
effect
found
mpa
deriv
compound
exhibit
poor
activ
group
microorgan
suscept
observ
analyz
result
seen
peptid
deriv
mpa
better
activ
parent
compound
case
strain
k
pneumonia
atcc
esbl
aureu
mrsa
atcc
valu
mic
lower
k
pneumonia
atcc
esbl
aureu
mrsa
atcc
antibiot
kanamycin
ampicillin
slightli
better
microbiolog
activ
aureu
mrsa
strain
reveal
deriv
contain
peptid
structur
balanin
moieti
differ
effect
tuftsin
skeleton
retrotuftsin
microbiolog
activ
amino
acid
ester
depend
substitu
configur
amino
acid
moieti
clearli
seen
case
threonin
arginin
enantiom
definit
less
activ
strain
although
damino
acid
enhanc
stabil
activ
substanc
due
improv
resist
proteas
obtain
result
suggest
natur
configur
test
compound
privileg
investig
bacteri
strain
deprotect
methyl
ester
chang
activ
consider
observ
signific
advantag
deriv
protect
methyl
ester
free
carboxyl
group
notic
strain
bacteria
could
explain
better
cell
membran
penetr
due
lower
polar
receiv
new
mpa
deriv
use
edci
condens
reagent
obtain
compound
test
five
differ
bacteri
cell
line
analyz
result
conclud
mpa
modif
promis
aureu
modif
promis
k
pneumonia
note
compound
free
carboxyl
group
exhibit
poor
activ
group
microorgan
microbiolog
activ
amino
acid
ester
depend
substitu
configur
amino
acid
moieti
found
deriv
configur
much
less
activ
l
configur
result
confirm
structur
modif
mpa
deriv
design
toward
antimicrobi
properti
reaction
perform
inert
atmospher
magnet
stir
dmf
purifi
distil
benzenewat
reaction
monitor
tlc
merck
silica
gel
precoat
plate
follow
solvent
system
volum
use
tlc
develop
ch
cl
meoh
ch
cooh
vv
valu
bold
type
mic
lowest
concentr
caus
complet
inhibit
growth
decreas
number
bacteri
popul
anoth
valu
sign
concentr
inhibit
growth
rel
posit
control
valu
sign
concentr
caus
poor
growth
inhibit
less
control
ni
inhibitori
effect
compound
concentr
use
stimul
growth
amino
acid
methyl
ester
hydrochlorid
mmol
mpa
mmol
dmap
mmol
dissolv
ml
anhydr
dmf
solut
cool
c
ice
bath
ad
mmol
edci
case
mmol
dmf
use
stir
continu
nitrogen
c
h
room
temperatur
progress
reaction
control
tlc
complet
synthesi
solvent
evapor
reduc
pressur
use
vacuum
pump
product
purifi
prepar
thin
layer
chromatographi
structur
synthes
deriv
establish
spectroscop
method
h
nmr
c
nmr
ms
hplcm
hydrolysi
ester
carri
remov
methyl
ester
carboxyl
group
methyl
ester
mmol
dissolv
ml
methanol
ad
g
mmol
lithium
hydroxid
monohydr
dissolv
ml
water
mixtur
stir
magnet
stirrer
h
room
temperatur
solut
acidifi
n
hcl
extract
ethyl
acet
etoac
extract
dri
mgso
evapor
purifi
prepar
thin
layer
chromatographi
respect
solvent
system
ad
produc
compound
procedur
synthesi
compound
mix
anhydrid
method
publish
previous
bocprotect
group
remov
treatment
tfa
peptid
mmol
mpa
mmol
tea
mmol
dissolv
ml
anhydr
dmf
solut
cool
c
ice
bath
follow
addit
mmol
dmf
reaction
mixtur
stir
spheric
flask
fill
inert
ga
nitrogen
c
h
room
temperatur
h
progress
reaction
control
tlc
plate
complet
synthesi
solvent
distil
reduc
pressur
use
vacuum
pump
product
purifi
use
prepar
thinlay
chromatographi
compound
mmol
treat
ml
chloroform
follow
addit
ml
diethylamin
dea
deprotect
reaction
carri
room
temperatur
h
control
tlc
solvent
distil
reduc
pressur
use
vacuum
pump
product
purifi
use
prepar
thinlay
chromatographi
peptid
mmol
mpa
mmol
dmap
mmol
dissolv
ml
anhydr
dmf
solut
cool
c
ice
bath
edci
ad
whole
stir
magnet
stirrer
spheric
flask
inert
ga
nitrogen
c
h
room
temperatur
h
progress
reaction
control
tlc
plate
complet
synthesi
solvent
distil
reduc
pressur
use
vacuum
pump
product
purifi
use
prepar
thinlay
chromatographi
compound
mmol
treat
ml
chloroform
follow
addit
ml
diethylamin
dea
deprotect
reaction
control
tlc
plate
solvent
distil
reduc
pressur
use
vacuum
pump
product
purifi
use
prepar
thinlay
chromatographi
begin
experi
effect
solvent
dmso
concentr
rang
bacteri
cell
viabil
investig
measur
od
plate
solid
medium
bacteri
growth
h
incub
compar
control
strain
without
dmso
impact
dmso
bacteri
cell
determin
concentr
research
done
triplic
stock
solut
conjug
mycophenol
acid
prepar
dmso
serial
dilut
made
water
growth
medium
final
concentr
mgl
solut
frozen
thaw
discard
screen
sensit
bacteria
mpa
deriv
perform
mic
test
mic
determin
microdilut
method
mueller
hinton
broth
ii
mhb
ii
polystyren
microtiterpl
accord
european
committe
antimicrobi
suscept
test
eucast
recommend
cell
bacteri
cultur
logarithm
growth
phase
dilut
medium
ratio
suspens
dilut
salin
receiv
mcfarland
scale
titrat
plate
ml
mhb
ii
medium
appli
ml
compound
solut
ad
first
well
column
serial
doubl
dilut
made
case
compound
rang
mgml
mgml
case
compound
rang
mgml
mgml
two
convent
antibiot
ampicillin
sigma
kanamycin
sigma
use
control
ampicillin
rang
concentr
mgml
kanamycin
mgml
final
ml
suitabl
bacteri
suspens
inocul
well
achiev
cellsml
inocul
plate
incub
c
h
mic
record
evalu
perform
spectrophotometr
plateread
uvvi
fluoresc
micropl
reader
eppendorf
od
visual
mic
determin
spectrophotometr
techniqu
defin
smallest
concentr
compound
inhibit
bacteri
cell
growth
express
respect
bacteri
growth
arrest
confirm
result
resazurin
ebas
assay
also
use
resazurin
oxidationreduct
indic
use
evalu
cell
growth
pink
uncolor
indic
growth
blue
inhibit
growth
resinazurin
ml
aqueou
solut
ad
well
sampl
incub
c
h
dark
measur
absorb
visual
evalu
color
accord
control
made
lowest
concentr
color
chang
occur
taken
mic
valu
mbc
valu
possibl
determin
case
mic
valu
determin
replic
independ
experi
data
collect
statist
test
anova
parametr
test
kruskalwilli
nonparametr
test
statist
work
done
use
rstudio
use
microsoft
excel
calcul
assum
p
statist
signific
